期刊
JOURNAL OF PHARMACOLOGICAL SCIENCES
卷 108, 期 1, 页码 56-62出版社
JAPANESE PHARMACOLOGICAL SOC
DOI: 10.1254/jphs.08144FP
关键词
arterial baroreflex; Parkinson's disease; baroreflex sensitivity; blood pressure variability; sinoaortic denervation
资金
- National Natural Science Foundation of China [30670833, 30672456, 30730106]
- National Hi-Technology Research & Development Program [2006AA02Z4C1]
- Science and Technology Development Foundation of Shanghai [07JC14065]
Patients with Parkinson's disease (PD) often have attenuated baroreflex function, which may occur before the onset of PD-associated movement disorders. The aim of the present study was to test whether impaired arterial baroreflex (ABR) function could contribute to the pathogenesis of PD. 6-Hydroxydopamine (8 mu g in 4 mu l) was microinjected into the left substantia nigra of rats to establish unilateral PD models, and bilateral PD models were established in rats by administration of rotenone by osmotic minipump for four weeks, at a dose of 2.5 mg.kg(-1).day(-1). An ABR dysfunction model was obtained by performing sinoaortic denervation (SAD). Hemodynamic variables were determined in conscious rats. PD-like symptoms and dopamine content in corpus striatum (CS) were also assessed. 6-Hydroxydopamine and rotenone treatment and SAD were associated with enhanced blood pressure variability (BPV) and blunted baroreflex sensitivity (BRS). Rotenone, but not SAD, significantly reduced dopamine content in the CS, induced catalepsy, and inhibited rearing and exploratory behavior. SAD before the administration of rotenone did not aggravate the rotenone-induced dopaminergic lesion. Our findings do not support the presumption that ABR dysfunction contributes to the pathogenesis of PD in rats.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据